Reviews of BPL-003 – Mebufotenin benzoate (5-MeO-DMT) nasal spray
No reviews yet. Share the first one.
BPL-003 – Mebufotenin benzoate (5-MeO-DMT) nasal spray by AtaiBeckley
BPL-003 is an investigational nasal spray being developed for treatment-resistant depression (TRD). Its Phase 3 program was reported on track to begin in Q2 2026. Investigational; not for sale.
Guides about BPL-003 – Mebufotenin benzoate (5-MeO-DMT) nasal spray